CLINICAL_TRIALS
trial_result
· 2019-09-04
Clinical Trial Update: Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) [Phase 2]
Summary
Phase 2 trial for molecularly determined treatment in diffuse intrinsic pontine glioma (DIPG) has been terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Karen D. Wright MD | Conditions: Diffuse Intrinsic Pontine Glioma | Phase 2 | Status: TERMINATED | Results posted: 2019-09-04